Clinical Trial Update: Validation of Bulbicam for Parkinson- and Ataxia-patients

View source ↗

Summary

A clinical trial validating Bulbicam for Parkinson's disease and ataxia has completed. The snippet does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia
• Parkinson Disease

Drugs mentioned

• Bulbicam

Snippet

Sponsor: Meddoc | Conditions: Parkinson Disease, Ataxia | Status: COMPLETED